SCHEMBL18735328

SCHEMBL18735328

CCOC(=O)C(NC(=O)C(C)CC)C(C)SC(=O)CC(=O)C(=O)OC

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 8/20 0.32
▸ METAP1 P53582 6/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735321 0.94 METAP2 (0.33) METAP2METAP1
SCHEMBL18735320 0.90 METAP2 (0.31) METAP2METAP1
SCHEMBL18735333 0.90 METAP2 (0.33) METAP2METAP1
SCHEMBL18735060 0.87 KMT2A (0.31) METAP2METAP1
SCHEMBL18735062 0.85 MGAM (0.38) METAP2METAP1
SCHEMBL18735319 0.84 KMT2A (0.31) METAP2METAP1
SCHEMBL18735334 0.83 METAP2 (0.34) METAP2METAP1
SCHEMBL18734930 0.82 — —
SCHEMBL18735052 0.82 LMNA (0.32) —
SCHEMBL18734946 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback